Lpath Nexus LT1009-Oph-003

Status: Completed

ClinicalTrials.gov Identifier: NCT01414153

Lpath Nexus LT1009-Oph-003: 4 monthly injections of iSonep given alone or in combination with Lucentis or Avastin in patients with wet AMD.

Condition: Exudative Age-Related Macular Degeneration

Study Type: Interventional

Duration:  34 months

Eligibility:

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.